Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors

• Takeshi Harada,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Shuji Ozaki ,

  * E-mail: ozaki@tph.gr.jp

  Affiliation Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan

  ⨯
• Asuka Oda,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Daisuke Tsuji,

  Affiliation Department of Medicinal Biotechnology, Graduate School of Pharmaceutical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Akishige Ikegame,

  Affiliation Division of Medical Technology, Tokushima University Hospital, Tokushima, Japan

  ⨯
• Masami Iwasa,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Kengo Udaka,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Shiro Fujii,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Shingen Nakamura,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Hirokazu Miki,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Kumiko Kagawa,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Yoshiaki Kuroda,

  Affiliation Department of Hematology and Oncology, RIRBM, Hiroshima University, Hiroshima, Japan

  ⨯
• Shigeto Kawai,

  Affiliation Research Division, Forerunner Pharma Research Co. Ltd., Tokyo, Japan

  ⨯
• Kohji Itoh,

  Affiliation Department of Medicinal Biotechnology, Graduate School of Pharmaceutical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• Hisafumi Yamada-Okabe,

  Affiliation Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan

  ⨯
• Toshio Matsumoto,

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
•  [ ... ],
• Masahiro Abe

  Affiliation Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan

  ⨯
• [ view all ]
• [ view less ]